Skip to main content
. 2017 Jan 25;15(3):1109–1116. doi: 10.3892/mmr.2017.6147

Table III.

Characteristics of ME formulation 1–5 and the skin permeation parameters of phenylethanoid glycoside when delivered by these formulations.

Characteristics of MEs

Formulation Size (nm) PDI pH Viscosity (mPa.s) Skin permeation parameter Jss (µg/cm−2/h−1)
ME1 79.21±0.01 0.236±0.05 7.21±0.01 80.51±0.87b (P=0.0076)   69.57±0.78b (P=0.0094)
ME2 37.91±0.42 0.187±0.03 6.98±0.01 47.52±0.54b (P=0.0089) 44.326±0.84b (P=0.0052)
ME3 67.71±0.13 0.243±0.01 6.83±0.06 60.49±1.34b (P=0.0094) 79.859±0.12a (P=0.039)
ME4 45.32±0.04 0.321±0.01 7.09±0.05 43.27±0.21b (P=0.0059) 58.332±0.39b (P=0.0063)
ME5 30.56±0.08 0.197±0.02 6.54±0.03 30.43±0.12 (P<0.0001) 86.795±0.23 (P<0.00010)

ME, microemulsion; PDI, polydisparity index; Jss, penetration rate.

a

P<0.05

b

P<0.01 vs. permeation rate of ME5.